FDA Study Population Requirement for BE Studies: Ethics or Science [Regulatives / Guidelines]

posted by bebac_fan – US, 2018-05-15 20:57 (1301 d 23:40 ago) – Posting: # 18767
Views: 1,876

Hi Obinoscopy,

Thanks for bringing this up for discussion. We can all think of many examples where PK in intended populations may be different than the general. However, it is hard to think of situations where a physiological state will selectively alter the PK of a test drug.

After thinking for a bit, and quite a bit of stretching, I could come up with gastric pH (e.g. increased in elderly) maybe affecting BA for a pH liable dispersion matrix. Perhaps other formulation dependent things for reduced GI motility. But I think this is in general a "feel good" clause and not scientifically rooted.

Cheers
BF

Complete thread:

Activity
 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 8 (0 registered, 8 guests [including 6 identified bots]).
Forum time: Tuesday 19:38 CET (Europe/Vienna)

A big computer, a complex algorithm and a long time
does not equal science.    Robert Gentleman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5